Hemafagositik Lenfohistiyositozis Sebebi Olarak Kırım Kongo Kanamalı Ateşi

Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant 2010; 16(1): 82-9.

Gürgey A, Seçmeer G, Tavil B, et al. Secondary hemo- phagocytic lymphohistiocytosis in Turkish children. Pediatr Infect Dis J 2005;24;1116-1117.

Henter J-I, Elinder G, Ost A. Diagnostic guidelines for he- mophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29–33.

Janka GE, Schenider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.

Henter J-I, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004;50:157–174.

Henter JI, Horne AC, Arico ́ M, et al. HLH-2004: Diagnos- tic and Therapeutic Guidelines for Hemophagocytic Lympho- histiocytosis. Pediatr Blood Cancer 2007;48:124–131.

Adams MJ, Lefkowitz EJ, King AM, Harrach B, Harrison RL, Knowles NJ, et al. Changes to taxonomy and the international code of virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch Virol 2017; 162(8): 2505-38.

Ergönül Ö. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6(4): 203-14.

Güneş T. Kırım-Kongo hemorajik ateşi. Mikrobiyol Bul 2006; 40:279-87.

Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005; 54(4): 385-9.

Whitehouse CA. Crimean–Congo hemorrhagic fever. Antiviral Res 2004; 64(3): 145-60.

Schnittler HJ, Feldmann H. Viral hemorrhagic fever–a vascular disease? Thromb Haemost 2003; 89(06): 967-72.

Chen J, Cosgriff T. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagul Fibrinolysis 2000; 11(5): 461-83.

Connolly-Andersen A-M. Endothelial cells, pp:17-18. In: Pathogenesis of an emerging pathogen-Crimean- Congo Hemorrhagic Fever Virus. Tumor and Biology. 2010. Repro Print AB, Stockholm.

Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21:245-253.

Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immu- nol. 2006;6:410-5.

Nagafuji K, Nonami A, Kumano T, et al. Perfo- rin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica. 2007;92:978- 81.

Bryceson YT, Rudd E, Zheng C, et al. Defective cyto- toxic lymphocyte degranulation in syntaxin-11 defi- cient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood. 2007;110:1906-15.

Han AR, Lee HR, Park BB, et al. Lymphoma-associa- ted hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol. 2007;86:493-8.

Ueda I, Kurokawa Y, Koike K, et al. Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol. 2007;82:427-32.

Santoro A, Cannella S, Bossi G, et al. Novel Munc13- 4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis.J Med Genet. 2006;43:953-60.

Tapısız A, Belet N, Ciftçi E, Ince E, Dogru U. Hemop- hagocytic lymphohistiocytosis associated with vis- ceral Leishmaniasis. J Trop Pediatr. 2007; [Epub ahead of print]

Celik U, Alabaz D, Alhan E, Bayram I, Celik T. Diag- nostic dilemma in an adolescent boy: hemophago- cytic syndrome in association with Kala Azar. Am J Med Sci. 2007;334:139-41.

Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheu- matol. 2007;34:1133-8.

Filipovich A, McClain K, Grom A. Histiocytic disorders: recent insights into pathophysiology and practical guidelines. Biol Blood Marrow Transplant 2010; 16(1): 82-9.

Gürgey A, Seçmeer G, Tavil B, et al. Secondary hemo- phagocytic lymphohistiocytosis in Turkish children. Pediatr Infect Dis J 2005;24;1116-1117.

Henter J-I, Elinder G, Ost A. Diagnostic guidelines for he- mophagocytic lymphohistiocytosis. The FHL Study Group of the Histiocyte Society. Semin Oncol 1991;18:29–33.

Janka GE, Schenider EM. Modern management of children with haemophagocytic lymphohistiocytosis. Br J Haematol 2004;124:4-14.

Henter J-I, Tondini C, Pritchard J. Histiocyte disorders. Crit Rev Oncol Hematol 2004;50:157–174.

Henter JI, Horne AC, Arico ́ M, et al. HLH-2004: Diagnos- tic and Therapeutic Guidelines for Hemophagocytic Lympho- histiocytosis. Pediatr Blood Cancer 2007;48:124–131.

Adams MJ, Lefkowitz EJ, King AM, Harrach B, Harrison RL, Knowles NJ, et al. Changes to taxonomy and the international code of virus classification and nomenclature ratified by the International Committee on Taxonomy of Viruses (2017). Arch Virol 2017; 162(8): 2505-38.

Ergönül Ö. Crimean-Congo haemorrhagic fever. Lancet Infect Dis 2006; 6(4): 203-14.

Güneş T. Kırım-Kongo hemorajik ateşi. Mikrobiyol Bul 2006; 40:279-87.

Bakir M, Ugurlu M, Dokuzoguz B, Bodur H, Tasyaran MA, Vahaboglu H, et al. Crimean-Congo haemorrhagic fever outbreak in Middle Anatolia: a multicentre study of clinical features and outcome measures. J Med Microbiol 2005; 54(4): 385-9.

Whitehouse CA. Crimean–Congo hemorrhagic fever. Antiviral Res 2004; 64(3): 145-60.

Schnittler HJ, Feldmann H. Viral hemorrhagic fever–a vascular disease? Thromb Haemost 2003; 89(06): 967-72.

Chen J, Cosgriff T. Hemorrhagic fever virus-induced changes in hemostasis and vascular biology. Blood Coagul Fibrinolysis 2000; 11(5): 461-83.

Connolly-Andersen A-M. Endothelial cells, pp:17-18. In: Pathogenesis of an emerging pathogen-Crimean- Congo Hemorrhagic Fever Virus. Tumor and Biology. 2010. Repro Print AB, Stockholm.

Janka GE. Hemophagocytic syndromes. Blood Rev. 2007;21:245-253.

Filipovich AH. Hemophagocytic lymphohistiocytosis and related disorders. Curr Opin Allergy Clin Immu- nol. 2006;6:410-5.

Nagafuji K, Nonami A, Kumano T, et al. Perfo- rin gene mutations in adult-onset hemophagocytic lymphohistiocytosis. Haematologica. 2007;92:978- 81.

Bryceson YT, Rudd E, Zheng C, et al. Defective cyto- toxic lymphocyte degranulation in syntaxin-11 defi- cient familial hemophagocytic lymphohistiocytosis 4 (FHL4) patients. Blood. 2007;110:1906-15.

Han AR, Lee HR, Park BB, et al. Lymphoma-associa- ted hemophagocytic syndrome: clinical features and treatment outcome. Ann Hematol. 2007;86:493-8.

Ueda I, Kurokawa Y, Koike K, et al. Late-onset cases of familial hemophagocytic lymphohistiocytosis with missense perforin gene mutations. Am J Hematol. 2007;82:427-32.

Santoro A, Cannella S, Bossi G, et al. Novel Munc13- 4 mutations in children and young adult patients with haemophagocytic lymphohistiocytosis.J Med Genet. 2006;43:953-60.

Tapısız A, Belet N, Ciftçi E, Ince E, Dogru U. Hemop- hagocytic lymphohistiocytosis associated with vis- ceral Leishmaniasis. J Trop Pediatr. 2007; [Epub ahead of print]

Celik U, Alabaz D, Alhan E, Bayram I, Celik T. Diag- nostic dilemma in an adolescent boy: hemophago- cytic syndrome in association with Kala Azar. Am J Med Sci. 2007;334:139-41.

Behrens EM, Beukelman T, Paessler M, Cron RQ. Occult macrophage activation syndrome in patients with systemic juvenile idiopathic arthritis. J Rheu- matol. 2007;34:1133-8.